Edition:
United States

Evotec AG (EVTG.DE)

EVTG.DE on Xetra

14.70EUR
11:35am EST
Change (% chg)

€-0.37 (-2.46%)
Prev Close
€15.07
Open
€14.87
Day's High
€14.98
Day's Low
€14.55
Volume
952,121
Avg. Vol
2,148,621
52-wk High
€22.50
52-wk Low
€7.06

Latest Key Developments (Source: Significant Developments)

Evotec, Apeiron Biologics receive milestone payment from Sanofi
Monday, 8 Jan 2018 01:31am EST 

Jan 8 (Reuters) - Evotec Ag ::SAYS ‍EVOTEC AND APEIRON ACHIEVE FIRST MILESTONE IN IMMUNO-ONCOLOGY ALLIANCE WITH SANOFI​.SAYS ‍MILESTONE PAYMENT OF EUR 3 M WILL BE SPLIT EQUALLY BETWEEN TWO BIOTECH COMPANIES​.SAYS ‍SUCCESS PAYMENT WAS TRIGGERED WHEN PARTNERS SUCCESSFULLY ADVANCED AN UNDISCLOSED, NOVEL IMMUNO-ONCOLOGY SMALL MOLECULE INTO LATE-STAGE PRE-CLINICAL DEVELOPMENT​.SAYS ‍UNDER ALLIANCE, THREE COMPANIES WORK TOGETHER TO IDENTIFY SMALL MOLECULE LEADS AND TARGETS FOR NEXT-GENERATION THERAPIES IN IMMUNO-ONCOLOGY​.  Full Article

Evotec affirms guidance after 9-month core profit jump
Wednesday, 8 Nov 2017 01:31am EST 

Nov 8 (Reuters) - Evotec Ag :9M revenue rose 42 percent to 170.9 million eur.‍9M adjusted group EBITDA up 28% to eur 39.3 m (9m 2016: eur 30.6 m)​.Says ‍guidance 2017 confirmed​.  Full Article

Abivax and Evotec enter into strategic collaboration
Thursday, 7 Sep 2017 01:31am EDT 

Sept 7 (Reuters) - ABIVAX SA : :ABIVAX AND EVOTEC ENTER INTO STRATEGIC COLLABORATION TO DEVELOP NOVEL ANTIVIRAL AGENTS.  Full Article

Evotec completes acquisition of Aptuit
Wednesday, 16 Aug 2017 01:31am EDT 

Aug 16 (Reuters) - Evotec :Says completes acquisition of aptuit.  Full Article

Evotec confirms outlook after H1 core profit jump
Thursday, 10 Aug 2017 01:30am EDT 

Aug 10 (Reuters) - Evotec AG :H1 revenue rose 37 percent to 103.4 million eur.Group revenues: 37% increase to eur 103.4 m (h1 2016: eur 75.5 m);.Adjusted group EBITDA increased by 64%to eur 26.0 m (h1 2016: eur 15.8 m);.Strong strategic liquidity position of eur 187.0 m (prior to aptuit acquisition).research and development expenses slightly decreased by 5% to eur 8.5 m (h1 2016: eur 9.0 m).All elements of financial guidance comfortably confirmed.  Full Article

Evotec expands collaboration with Storm Therapeutics
Thursday, 27 Jul 2017 01:31am EDT 

July 27 (Reuters) - Evotec AG :Says expands collaboration with Storm Therapeutics on its RNA epigenetics platform.Says no financial details were disclosed.  Full Article

Evotec receives grant funding from IFB Hamburg
Thursday, 6 Jul 2017 01:29am EDT 

July 6 (Reuters) - Evotec AG :Says received funding from IFB Hamburg to identify antibody-mediated t-cell immunotherapies.  Full Article

Evotec announces strategic investment in Facio Therapies
Tuesday, 20 Jun 2017 01:30am EDT 

June 20 (Reuters) - Evotec AG :Announces strategic investment in Facio Therapies to support development of novel FSHD therapy.Says to participate in Facio Therapies' 2017 funding round alongside members of FSHD community (total volume: 4.8 mln euros).  Full Article

Evotec receives milestone as part of alliance with Bayer
Monday, 22 May 2017 01:29am EDT 

May 22 (Reuters) - Evotec AG :Evotec receives pre-clinical milestone as part of its endometriosis alliance with Bayer.Payment of approx. Eur 5 m to Evotec for transition of a programme into pre-clinical development for treatment of endometriosis.This milestone was achieved under successful strategic alliance between Evotec and Bayer entered in october 2012.  Full Article

Evotec Q1 core profit up 13 pct, guidance affirmed
Wednesday, 10 May 2017 01:33am EDT 

May 10 (Reuters) - Evotec AG :Q1 revenue rose 34 percent to 50.2 million eur.Novo a/s new strategig investor in evotec.Adjusted group EBITDA increased to eur 13.2 m (2016: eur 7.2 m);.Says guidance 2017 confirmed.Strong strategic liquidity position of eur 185.0 m.Source text for Eikon: ID:nEQbR0x2Y.  Full Article

BRIEF-Evotec, Apeiron Biologics receive milestone payment from Sanofi

* SAYS ‍EVOTEC AND APEIRON ACHIEVE FIRST MILESTONE IN IMMUNO-ONCOLOGY ALLIANCE WITH SANOFI​